Nanomedicine News

RSS

Nanoparticle Paclitaxel with Carboplatin Effective than Commercial Gemcitabine-Carboplatin

Decision Resources, a research and consultative firm for pharmaceutical and healthcare issues, offers analysis on the latest developments in the non-small-cell lung cancer drug market.

30 Mar 2012

Comprehensive Book on Applied Aspects of Nanotechnology in Health Care

Research and Markets has added a new book, titled, "Nanotechnology in Health Care" to its collection.

From Research and Markets 28 Mar 2012

BIONOVA’s Skincare Products Now Include NANO-COMPLEX

When it made its entry into the beauty market, BIONOVA promised to offer healthy skin with unprecedented results through life science nanotechnology. Today, the company has succeeded in delivering the results it promised and has become one of the most trusted and well-known skincare brands.

28 Mar 2012

Nanofibers and Nanofilaments Offer Potential Solutions in Regenerative Medicine

According to Samuel I. Stupp, Ph.D., regenerative medicine can have a significant impact on healthcare cost and the quality of life.

27 Mar 2012

Blue Spark to Demonstrate Applications of Low-Voltage Printed Batteries at German Conference

Blue Spark Technologies, a provider of thin, environmentally friendly, flexible printed batteries, has disclosed that the company will participate in Printed Electronics Europe 2012.

27 Mar 2012

Novavax to Discuss Phase I Study Results of RSV Nanoparticle Vaccine at Turkey Conference

Louis F. Fries III, Vice President of Clinical and Medical Affairs at Novavax, will present the Phase I clinical study results of the company’s recombinant nanoparticle vaccine candidate for respiratory syncytial virus (RSV) at the XIV International Symposium on Respiratory Viral Infections to be conducted from March 24 to 26, 2012 in Istanbul, Turkey.

From Novavax Inc. 26 Mar 2012